Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

DXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising ...

Dexcom, the local maker of continuous glucose monitors, received a warning letter from the Food and Drug Administration last ...

Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.

Roche is planning to launch the device in select European countries soon. Following the receipt of the FDA letter, DexCom’s share price has been on a declining trend. However, few analysts do ...

Beta Bionics recently brought its iLet bionic pancreas to market in 2023 and completed an IPO to become a publicly-traded ...

In this article, we are going to take a look at where DexCom ... Most of these devices are standard CGMs, with only a few being implanted sensors. 133 products are either approved or in the ...

(COLORADO SPRINGS) — A medical device for diabetes called the Dexcom ... For thousands of people across the country, access to the Dexcom G7 sensor is strained because of a supply shortage.

At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system,1 ...

The latest trend in health and fitness tracking may sound familiar: wearing continuous glucose monitors (CGMs). Many people ...